U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Carcinogenicity Study Protocol Submissions
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Carcinogenicity Study Protocol Submissions May 2002

Final
Docket Number:
FDA-2000-D-1405
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guidance is intended to inform sponsors of the types of information the Center for Drug Evaluation and Research (CDER) relies on when evaluating protocols for animal carcinogenicity studies.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2000-D-1405.

Back to Top